We demonstrated that high levels of immune checkpoint receptors on TAICs in pancreatic cancer correlate with better OS, whereas high PD-L1 expression on TCs is associated with unfavorable outcomes. This evidence concerns the gene CD274 and familial pancreatic carcinoma.